Fatma Al Qutami (Fatma Alqutami)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Endometrial Cancer

Molecular Docking

Patient Reported Outcomes

Top Venues

Life (Basel, Switzerland)

JMIR research protocols

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Fatma Al Qutami, Walaa AlHalabi, Aswathy Vijayakumar, Surendra Singh Rawat, Abubakr H Mossa, Manju Nidagodu Jayakumar, Baila Samreen, Mahmood Yaseen Hachim
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer. Cancers 16 (4) (2024)
Fatma Al Qutami, Walaa AlHalabi, Aswathy Vijayakumar, Surendra Singh Rawat, Abubakr H Mossa, Manju Nidagodu Jayakumar, Baila Samreen, Mahmood Yaseen Hachim
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer. Cancers 16 (4) (2024)
Rachid Kaddoura, Fatma Al Qutami, Mohamed Asbaita, Mahmood Yaseen Hachim
In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers. Life (Basel, Switzerland) 13 (2) (2023)
Fatma Al Qutami, Walaa Al Halabi, Mahmood Yaseen Hachim
Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization. International journal of molecular sciences 24 (17) (2023)
Rachid Kaddoura, Fatma Al Qutami, Mohamed Asbaita, Mahmood Yaseen Hachim
In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers. Life (Basel, Switzerland) 13 (2) (2023)
Rachid Kaddoura, Fatma Al Qutami, Mohamed Asbaita, Mahmood Yaseen Hachim
In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers. Life (Basel, Switzerland) 13 (2) (2023)
Rachid Kaddoura, Fatma Al Qutami, Mohamed Asbaita, Mahmood Yaseen Hachim
In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers. Life (Basel, Switzerland) 13 (2) (2023)
Rachid Kaddoura, Hardik Ghelani, Fatma Al Qutami, Hala Altaher, Mahmood Yaseen Hachim, Reem Kais Jan
Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis. Life (Basel, Switzerland) 13 (3) (2023)
William Atiomo, Fatma Al Qutami, Sara Albasha, Mahmood Yaseen Hachim
Deciphering the Role of Insulin-Like Growth Factor 1 in Endometrial Cancer in Patients With Polycystic Ovary Syndrome: Protocol for a Methodological Approach Using Cell Culture Experiments. JMIR research protocols 12 (2023)
Rachid Kaddoura, Hardik Ghelani, Fatma Al Qutami, Hala Altaher, Mahmood Yaseen Hachim, Reem Kais Jan
Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis. Life (Basel, Switzerland) 13 (3) (2023)
Rachid Kaddoura, Hardik Ghelani, Fatma Al Qutami, Hala Altaher, Mahmood Yaseen Hachim, Reem Kais Jan
Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis. Life (Basel, Switzerland) 13 (3) (2023)
Mahmood Yaseen Hachim, Fatma Al Qutami, Ibrahim Yaseen Hachim, Saba Al Heialy, Hauke Busch, Rifat Akram Hamoudi, Qutayba Hamid
The Role of Systems Biology in Deciphering Asthma Heterogeneity. Life (Basel, Switzerland) 12 (10) (2022)